1. Home
  2. ERAS vs CVBF Comparison

ERAS vs CVBF Comparison

Compare ERAS & CVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Erasca Inc.

ERAS

Erasca Inc.

HOLD

Current Price

$19.18

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Logo CVB Financial Corporation

CVBF

CVB Financial Corporation

HOLD

Current Price

$22.35

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERAS
CVBF
Founded
2018
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.7B
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
ERAS
CVBF
Price
$19.18
$22.35
Analyst Decision
Strong Buy
Buy
Analyst Count
12
3
Target Price
$14.25
$24.50
AVG Volume (30 Days)
5.5M
1.9M
Earning Date
05-08-2026
04-22-2026
Dividend Yield
N/A
3.95%
EPS Growth
36.23
5.56
EPS
N/A
0.38
Revenue
N/A
N/A
Revenue This Year
N/A
$21.47
Revenue Next Year
N/A
$15.21
P/E Ratio
N/A
$58.34
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$17.95
52 Week High
$24.28
$23.34

Technical Indicators

Market Signals
Indicator
ERAS
CVBF
Relative Strength Index (RSI) 73.23 59.53
Support Level $12.36 $18.20
Resistance Level $24.28 N/A
Average True Range (ATR) 1.21 0.46
MACD 0.32 0.00
Stochastic Oscillator 90.66 63.99

Price Performance

Historical Comparison
ERAS
CVBF

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

About CVBF CVB Financial Corporation

CVB Financial Corp is the holding company for Citizens Business Bank. Citizens Business Bank offers banking, lending, and investing services. It provides a full complement of lending products, including commercial, agribusiness, consumer, SBA, real estate, and construction loans, as well as equipment and vehicle leasing. Commercial products include lines of credit and other working capital financing, accounts receivable lending and letters of credit. It is a community bank with one reportable operating segment.

Share on Social Networks: